health benefits of tirzepatide Study sees potential obesity drug in tackling type 2 diabetes How Does Zepbound Support Weight

Participants began at a 2 mg starting dose and stepped up roughly every four weeks toward their assigned target

Introduction Irritable bowel syndrome (IBS) is a common gastrointestinal bowel disorder, characterized by recurrent abdominal pain and discomfort or alterations in bowel habits

Eating four to six smaller meals throughout the day, rather than three large ones, allows for more manageable digestion and may reduce bacterial fermentation

The emergence of glucagon-like peptide-1 (GLP-1) receptor agonists represents one of the most significant advances in obesity and diabetes treatment in recent decades

Results of the LEADER and SUSTAIN-6 trials: cardiovascular outcomes with GLP-1 receptor agonists

Cardiovasc Psychiatry Neurol